• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameCORDIS EXOSEAL VASCULAR CLOSURE DEVICE
Classification Namedevice, hemostasis, vascular
ApplicantCORDIS CORPORATION
PMA NumberP100013
Date Received04/01/2010
Decision Date05/19/2011
Product Code
MGB[ Registered Establishments with MGB ]
Docket Number 11M-0430
Notice Date 06/03/2011
Advisory Committee Cardiovascular
Clinical Trials NCT00345631
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Recalls CDRH Recalls
Approval Order Statement 
Approval for the exoseal vascular closure device. This device is indicated as follows: the exoseal vascular closure device (vcd) is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5f, 6f, or 7f vascular sheath introducer with up to 12 cm working length. Additionally, the exoseal vcd is indicated to reduce times to hemostasis and ambulation in patients who have undergone interventional catheterization procedures, using a standard 6f vascular sheath introducer up to a 12 cm working length, who have received preprocedural and/or intraprocedural glycoprotein (gp) iib/iiia inhibitor therapy.
Approval Order Approval Order
Supplements: S001 S002 S003 S004 S005 S006 S007 S008 S009 
S010 
-
-